CA-ENERO-GROUP
8.6.2021 15:02:15 CEST | Business Wire | Press release
Enero Group (ASX:EGG) has today announced the appointment of Heather Kernahan as Global Chief Executive Officer of Hotwire, the Group’s leading global technology communications consultancy. The appointment will see Kernahan report to Brent Scrimshaw, Enero Group CEO, effective 1 July 2021.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210608005467/en/
Barbara Bates, who has successfully led Hotwire for the past five years, will move into a newly created senior advisory role at Enero. Bates will help facilitate Enero Group’s M&A activities in North America and will continue to report to Brent Scrimshaw.
“I would like to thank Barbara for her leadership and drive in Hotwire being the successful, global technology communications consultancy that it is today. She has been an innovative, respected and transformational leader across nearly three decades in the global communications industry. I am delighted she will remain in the Group.
“This change provides an excellent opportunity for Heather Kernahan to lead the next phase of growth for Hotwire. Heather has demonstrated incredible leadership in tackling the challenges and opportunities of a rapidly-growing business in Hotwire USA. Heather has the skills, experience and appetite for growth and her appointment demonstrates the deep bench strength of the Hotwire leadership team. I am confident she will continue to drive the business’ momentum and push Hotwire to even greater heights,” said Brent Scrimshaw.
Commenting on her appointment, Heather Kernahan said: “There is no more exciting industry to be in than technology and I’m thrilled to lead the Hotwire team as we continue to grow. We have ambitious plans to bring more value to our fast growth and global tech clients, who are looking for an alternative to the big multinational agencies. Barbara has led a culture, team and business that is sought after by the largest tech companies in the world and I’m honoured to now lead this organisation. With 20 years behind us, we feel that we’re just getting started.”
Barbara Bates said: “I’ve had the privilege to work with so many amazing people during my time at Hotwire, and I’m exceptionally proud of what we’ve managed to create together. Hotwire is already one of the world’s most highly-regarded tech communications businesses and with Heather’s leadership, it has never been better positioned to grow further. I’m excited to stay connected to the Enero Group and I look forward to continue building on the Group’s strong momentum and ambition.”
Heather Kernahan joined Hotwire from Eastwick Communications, as president of Hotwire North America and Australia, after its acquisition in 2016 by Enero Group. In 2019, she was named Hotwire CEO of North America. Under her leadership the agency has experienced record growth. With over 20 years of industry experience, Kernahan has held senior marketing and executive leadership roles at fast growth and global technology organisations including Autodesk, Enphase Energy and Alias. Under her leadership, Hotwire has developed partnerships with technology companies including: Adobe, Facebook, McAfee, Commvault, NetApp and Pinterest. As a global tech expert and business leader she has been named one of 2020 SF Business Times’ 100 Most Influential Women and is the Board Chair of The PR Council. Kernahan holds an MBA in Sustainable Enterprise from Dominican University of California.
This announcement comes as Hotwire continues to expand the team while delivering outstanding business results and following the successful acquisition of McDonald Butler Associates in London last month. In the past year, Hotwire has continued its 20 years of industry leadership, being named 2020 Global Technology Agency of the Year by PRovoke Media, Best Places to Work in PR by PRWeek for two years in a row and recently recognised as one of the Best Companies to Work for in the UK by the Sunday Times . Current clients include Accenture, Adobe, AWS, Citrix, Dell Technologies, Deloitte, Delphix, DXC Technology, eBay, GoPro, Honeywell, IBM, McAfee, Pegasystems and PWC.
About Enero:
Headquartered in Sydney, Australia, Enero Group is a boutique network of marketing and communications businesses listed on the ASX (Australian Stock Exchange) that includes creative agency BMF, PR and integrated communications agencies Hotwire and CPR, strategic data consultancies The Leading Edge and The Digital Edge, digital agency Orchard and programmatic marketing specialist OB Media. www.enero.com .
About Hotwire
Hotwire is the global technology communication consultancy. Founded in 2000, we operate a worldwide network of wholly owned offices and partners serving a range of clients from scale ups to established multi-nationals. We unleash the possibilities of innovative technology through integrated communications that ignite curiosity, spark action and fuel success. We do this using our proprietary methodology which is underpinned by robust insight and strategy, purposeful creative, integrated planning and a core emphasis on measurement and evaluation. www.hotwireglobal.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210608005467/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom